New manufacturing method for therapeutic cells
| Reference number | |
| Coordinator | Nyctea Technologies AB |
| Funding from Vinnova | SEK 1 100 000 |
| Project duration | November 2023 - June 2025 |
| Status | Ongoing |
| Venture | Competence centre |
Purpose and goal
Develop a new method for the purification and isolation of therapeutic cells at a lower cost.
Expected effects and result
** Denna text är maskinöversatt ** The cost of producing therapeutic cells decreases, which increases the possibility of treating more patients and accelerates the development of new treatments. For För Nyctea, this means an opportunity to develop our business towards an important and rapidly growing customer segment in the pharmaceutical industry. Expected results are a functional prototype that is evaluated together with pilot customers. Data showing a more efficient production process leading to lower costs for manufacturing cell therapies.
Planned approach and implementation
** Denna text är maskinöversatt ** First, we develop an electrode that captures and releases cells using electrical signals. Later, we develop a process method to guarantee that the electrode is sterile. In the third step, we extensively verify that the cells we isolate retain their properties and function. After this, we build a bioreactor prototype and perform proof-of-concept studies and analysis. After a first cycle of product development, we re-iterate the process. Then we carry out tests with the first pilot customers.